Story Tag: Lutetium Therapy in India

Lu 177 Dotate Reduce the Risk of Cancer Spreading Growing, or Getting worse by 79% for patients with metastatic Net, as campared to a large dese of long acting octreetide.

Lu 177 Dotate Reduce the Risk of Cancer Spreading Growing, or Getting worse by 79% for patients with metastatic Net, as campared to a large dese of long acting octreetide. pin.it

ajay sharma ajay sharma 2 months ago in Health

Peptide receptor radionuclide therapy (PRRT) is fast proving to be a paradigm-shifting approach to the treatment of neuroendocrine tumors.For more information on PRRT, do call us at +91 98111 27080, or write to us at [email protected] or visit https://nuclearmedicinetherapy.in/treatments/prrt

1Upvote

Lu177 PRRT For Neuroendocrine Tumors (Nets) nuclearmedicinetreatment.blogspot.com

ajay sharma ajay sharma 3 months ago in Health

Unlike healthy cells, the neuroendocrine tumor cells or NET cells have proteins on their cell surface. These proteins, also known as receptors, bind themselves to hormones, such as somatostatin. Peptide Receptor Radionuclide Therapy or PRRT with lutetium 177 dotatate or Lu177 targets these receptors with radiopeptides and deliver a high dose of radiation to the tumor cells.

1Upvote

Lu177 PRRT For Neuroendocrine Tumors Nets vimeo.com

ajay sharma ajay sharma 3 months ago in Health

PRRT or Peptide Receptor Radionuclide Therapy is a type of Nuclear Medicine Therapy in which a cell-targeting protein or peptide is combined with a small amount of radioactive material that created a special type of radiopharmaceutical known as a Radiopeptide. This radiopeptide is injected into a Neuroendocrine Tumor patient’s bloodstream.Details Available at https://nuclearmedicinetherapy.in/blog/lu177-prrt-for-neuroendocrine-tumors-nets

1Upvote